267 related articles for article (PubMed ID: 26805394)
1. Blocking protein phosphatase 2A signaling prevents endothelial-to-mesenchymal transition and renal fibrosis: a peptide-based drug therapy.
Deng Y; Guo Y; Liu P; Zeng R; Ning Y; Pei G; Li Y; Chen M; Guo S; Li X; Han M; Xu G
Sci Rep; 2016 Jan; 6():19821. PubMed ID: 26805394
[TBL] [Abstract][Full Text] [Related]
2. Blocking Tyr265 nitration of protein phosphatase 2A attenuates nitrosative stress-induced endothelial dysfunction in renal microvessels.
Deng Y; Cai Y; Liu L; Lin X; Lu P; Guo Y; Han M; Xu G
FASEB J; 2019 Mar; 33(3):3718-3730. PubMed ID: 30521379
[TBL] [Abstract][Full Text] [Related]
3. Blocking protein phosphatase 2A with a peptide protects mice against bleomycin-induced pulmonary fibrosis.
Yu J; Deng Y; Han M
Exp Lung Res; 2020 Sep; 46(7):234-242. PubMed ID: 32584210
[TBL] [Abstract][Full Text] [Related]
4. A novel role of kallikrein-related peptidase 8 in the pathogenesis of diabetic cardiac fibrosis.
Du JK; Yu Q; Liu YJ; Du SF; Huang LY; Xu DH; Ni X; Zhu XY
Theranostics; 2021; 11(9):4207-4231. PubMed ID: 33754057
[No Abstract] [Full Text] [Related]
5. Role of endothelial-to-mesenchymal transition induced by TGF-β1 in transplant kidney interstitial fibrosis.
Wang Z; Han Z; Tao J; Wang J; Liu X; Zhou W; Xu Z; Zhao C; Wang Z; Tan R; Gu M
J Cell Mol Med; 2017 Oct; 21(10):2359-2369. PubMed ID: 28374926
[TBL] [Abstract][Full Text] [Related]
6. Endothelial-to-mesenchymal transition and renal fibrosis in ischaemia/reperfusion injury are mediated by complement anaphylatoxins and Akt pathway.
Curci C; Castellano G; Stasi A; Divella C; Loverre A; Gigante M; Simone S; Cariello M; Montinaro V; Lucarelli G; Ditonno P; Battaglia M; Crovace A; Staffieri F; Oortwijn B; van Amersfoort E; Gesualdo L; Grandaliano G
Nephrol Dial Transplant; 2014 Apr; 29(4):799-808. PubMed ID: 24463188
[TBL] [Abstract][Full Text] [Related]
7. CXCR7 attenuates the TGF-β-induced endothelial-to-mesenchymal transition and pulmonary fibrosis.
Guan S; Zhou J
Mol Biosyst; 2017 Sep; 13(10):2116-2124. PubMed ID: 28820530
[TBL] [Abstract][Full Text] [Related]
8. MiR-200a modulates TGF-β1-induced endothelial-to-mesenchymal shift via suppression of GRB2 in HAECs.
Zhang H; Hu J; Liu L
Biomed Pharmacother; 2017 Nov; 95():215-222. PubMed ID: 28846982
[TBL] [Abstract][Full Text] [Related]
9. Fibroblasts in kidney fibrosis emerge via endothelial-to-mesenchymal transition.
Zeisberg EM; Potenta SE; Sugimoto H; Zeisberg M; Kalluri R
J Am Soc Nephrol; 2008 Dec; 19(12):2282-7. PubMed ID: 18987304
[TBL] [Abstract][Full Text] [Related]
10. Lefty1 alleviates renal tubulointerstitial injury in mice with unilateral ureteral obstruction.
Xu C; Xu M; Wang W; Zhang J
Mol Med Rep; 2016 Jan; 13(1):901-8. PubMed ID: 26647776
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional regulation of endothelial-to-mesenchymal transition in cardiac fibrosis: role of myocardin-related transcription factor A and activating transcription factor 3.
Sharma V; Dogra N; Saikia UN; Khullar M
Can J Physiol Pharmacol; 2017 Oct; 95(10):1263-1270. PubMed ID: 28686848
[TBL] [Abstract][Full Text] [Related]
12. The role of miR-328 in high glucose-induced endothelial-to-mesenchymal transition in human umbilical vein endothelial cells.
Chen Y; Yang Q; Zhan Y; Ke J; Lv P; Huang J
Life Sci; 2018 Aug; 207():110-116. PubMed ID: 29859985
[TBL] [Abstract][Full Text] [Related]
13. Interactions of DPP-4 and integrin β1 influences endothelial-to-mesenchymal transition.
Shi S; Srivastava SP; Kanasaki M; He J; Kitada M; Nagai T; Nitta K; Takagi S; Kanasaki K; Koya D
Kidney Int; 2015 Sep; 88(3):479-89. PubMed ID: 25830763
[TBL] [Abstract][Full Text] [Related]
14. Hydroxysafflor Yellow A Ameliorates Renal Fibrosis by Suppressing TGF-β1-Induced Epithelial-to-Mesenchymal Transition.
Hu N; Duan J; Li H; Wang Y; Wang F; Chu J; Sun J; Liu M; Wang C; Lu C; Wen A
PLoS One; 2016; 11(4):e0153409. PubMed ID: 27088510
[TBL] [Abstract][Full Text] [Related]
15. MicroRNAs in kidney fibrosis and diabetic nephropathy: roles on EMT and EndMT.
Srivastava SP; Koya D; Kanasaki K
Biomed Res Int; 2013; 2013():125469. PubMed ID: 24089659
[TBL] [Abstract][Full Text] [Related]
16. Relaxin inhibits cardiac fibrosis and endothelial-mesenchymal transition via the Notch pathway.
Zhou X; Chen X; Cai JJ; Chen LZ; Gong YS; Wang LX; Gao Z; Zhang HQ; Huang WJ; Zhou H
Drug Des Devel Ther; 2015; 9():4599-611. PubMed ID: 26316699
[TBL] [Abstract][Full Text] [Related]
17. Naringin activates semaphorin 3A to ameliorate TGF-β-induced endothelial-to-mesenchymal transition related to atrial fibrillation.
Lai YJ; Chang SH; Tung YC; Chang GJ; Almeida C; Chen WJ; Yeh YH; Tsai FC
J Cell Physiol; 2024 May; 239(5):e31248. PubMed ID: 38501506
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of BRD4 attenuates transverse aortic constriction- and TGF-β-induced endothelial-mesenchymal transition and cardiac fibrosis.
Song S; Liu L; Yu Y; Zhang R; Li Y; Cao W; Xiao Y; Fang G; Li Z; Wang X; Wang Q; Zhao X; Chen L; Wang Y; Wang Q
J Mol Cell Cardiol; 2019 Feb; 127():83-96. PubMed ID: 30529267
[TBL] [Abstract][Full Text] [Related]
19. The regulatory peptide apelin: a novel inhibitor of renal interstitial fibrosis.
Wang LY; Diao ZL; Zhang DL; Zheng JF; Zhang QD; Ding JX; Liu WH
Amino Acids; 2014 Dec; 46(12):2693-704. PubMed ID: 25164121
[TBL] [Abstract][Full Text] [Related]
20. A small population of liver endothelial cells undergoes endothelial-to-mesenchymal transition in response to chronic liver injury.
Ribera J; Pauta M; Melgar-Lesmes P; Córdoba B; Bosch A; Calvo M; Rodrigo-Torres D; Sancho-Bru P; Mira A; Jiménez W; Morales-Ruiz M
Am J Physiol Gastrointest Liver Physiol; 2017 Nov; 313(5):G492-G504. PubMed ID: 28798084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
